Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEDROXYPROGESTERONE Cause Pulmonary embolism? 98 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Pulmonary embolism have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 1.2% of all adverse event reports for MEDROXYPROGESTERONE.

98
Reports of Pulmonary embolism with MEDROXYPROGESTERONE
1.2%
of all MEDROXYPROGESTERONE reports
7
Deaths
53
Hospitalizations

How Dangerous Is Pulmonary embolism From MEDROXYPROGESTERONE?

Of the 98 reports, 7 (7.1%) resulted in death, 53 (54.1%) required hospitalization, and 29 (29.6%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for MEDROXYPROGESTERONE.

What Other Side Effects Does MEDROXYPROGESTERONE Cause?

Meningioma (1,364) Drug dose omission by device (510) Device leakage (500) Incorrect dose administered by device (410) Drug ineffective (403) Off label use (390) Syringe issue (354) Needle issue (346) Headache (288) Device occlusion (284)

What Other Drugs Cause Pulmonary embolism?

RIVAROXABAN (3,282) LENALIDOMIDE (2,976) APIXABAN (2,714) ETHINYL ESTRADIOL\ETONOGESTREL (2,370) TESTOSTERONE (2,043) RITUXIMAB (1,764) ADALIMUMAB (1,663) PREDNISONE (1,586) METHOTREXATE (1,508) DEXAMETHASONE (1,336)

Which MEDROXYPROGESTERONE Alternatives Have Lower Pulmonary embolism Risk?

MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE MEDROXYPROGESTERONE vs MEFENAMIC ACID MEDROXYPROGESTERONE vs MEFLOQUINE MEDROXYPROGESTERONE vs MEGESTROL MEDROXYPROGESTERONE vs MEGLUMINE

Related Pages

MEDROXYPROGESTERONE Full Profile All Pulmonary embolism Reports All Drugs Causing Pulmonary embolism MEDROXYPROGESTERONE Demographics